WaveLight AG

WaveLight AG was founded in 1996 by the former Chairman of the Board of Directors, Max Reindl, and has quickly established itself as global technology leader in the area of refractive surgery. The internationally successful company domiciled in Erlangen develops and manufactures a wide product range of optimised treatment solutions for the high precision correction of visual impairments.

With its technology competence in the area of refractive surgery and consistently customer-oriented Customer Service and Support, WaveLight AG already laid the foundation very early for successful, global exploitation of the market. As early as 2003, WaveLight, as the first ever European manufacturer, obtained the approval of the USA FDA (Food and Drug Administration) health authority for the sale of the excimer laser for LASIK applications in the USA.

The employees of the company represent an important factor for the globally recognised quality of the WaveLight products. A highly motivated specialist team of more than 170 employees is continuously working on the optimisation of the WaveLight treatment and diagnosis systems and thus on the future success of the medical technology specialists from Erlangen, the so-called ‘Medical Valley’.

WaveLight was listed on the “New Market” of Deutsche Börse AG from the stock exchange flotation in September 1999 until the new segmentation of the stock exchange index at the end of the year 2002. WaveLight AG has been listed in the Prime Standard of Deutsche Börse AG since January 2003.

In the course of the takeover by the USA company Alcon, Inc. which currently holds more than 92% of WaveLight AG, the realisation of potential synergies, mainly in the areas of marketing and sales as well as research and development, is planned in order to further accelerate the market success of WaveLight laser systems.